|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Grupo de Neurofarmacología, Departamento de Ciencias Médicas, Facultad de Medicina, Universidad Castilla-La Mancha, Albacete, Spain (M.G.-L., M.F.G, R.M.M.-F.M., F.J.F.-G., J.J.); Department of Physiology and RCSI Neuroscience Research Centre, Royal College of Surgeons in Ireland, Dublin, Ireland (C.G.C., J.H.M.P.); Cell Signaling and Apoptosis Group, Departament de Ciències Mèdiques Bàsiques, University of Lleida and Hospital Arnau de Vilanova, Lleida, Spain (M.F.S., J.X.C.); and Centro Regional de Investigaciones Biomedicas, Albacete, Spain (M.G.-L., M.F.G., R.M.M.-F.M., F.J.F.-G., J.J.)
Malonate, an inhibitor of mitochondrial complex II, is a widely used toxin to study neurodegeneration in Huntington's disease and ischemic stroke. We have shown previously that malonate increased reactive oxygen species (ROS) production in human SH-SY5Y neuroblastoma cells, leading to oxidative stress, cytochrome c release, and apoptotic cell death. Expression of a green fluorescent protein-Bax fusion protein in SH-SY5Y neuroblastoma cells demonstrated a Bax redistribution from the cytosol to mitochondria after 12 to 24 h of malonate treatment that coincided with mitochondrial potential collapse and chromatin condensation. Inhibition of Bax translocation using furosemide, as well as Bax gene deletion, afforded significant protection against malonate-induced apoptosis. Further experiments revealed that malonate induced a prominent increase in the level of activated p38 mitogen-activated protein (MAP) kinase and that treatment with the p38 MAP kinase inhibitor SKF86002 potently blocked malonate-induced Bax translocation and apoptosis. Treatment with vitamin E diminished ROS production, reduced the activation status of p38 MAP kinase, inhibited Bax translocation, and protected against malonate-induced apoptosis. Our data suggest that malonate-induced ROS production and subsequent p38 MAP kinase activation mediates the activation of the pro-apoptotic Bax protein to induce mitochondrial membrane permeabilization and neuronal apoptosis.
Received for publication September 8, 2006.
Accepted for publication December 15, 2006.
Address correspondence to: Joaquin Jordán, Grupo de Neurofarmacología, Departamento de Ciencias Médicas, Facultad de Medicina, Universidad Castilla-La Mancha, 02006, Albacete, Spain. E-mail: joaquin.jordan{at}uclm.es
This article has been cited by other articles:
![]() |
Y. H. HAN, H. J. MOON, B. R. YOU, S. Z. KIM, S. H. KIM, and W. H. PARK The Effect of MAPK Inhibitors on Arsenic Trioxide-treated Calu-6 Lung Cells in Relation to Cell Death, ROS and GSH Levels Anticancer Res, October 1, 2009; 29(10): 3837 - 3844. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Juric, C.-C. Chen, and L. F. Lau Fas-Mediated Apoptosis Is Regulated by the Extracellular Matrix Protein CCN1 (CYR61) In Vitro and In Vivo Mol. Cell. Biol., June 15, 2009; 29(12): 3266 - 3279. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-F. Hu, M. Lu, Z.-Y. Wu, P. T.-H. Wong, and J.-S. Bian Hydrogen Sulfide Inhibits Rotenone-Induced Apoptosis via Preservation of Mitochondrial Function Mol. Pharmacol., January 1, 2009; 75(1): 27 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Garrofe-Ochoa, R. M. Melero-Fernandez de Mera, F. J. Fernandez-Gomez, J. Ribas, J. Jordan, and J. Boix BAX and BAK proteins are required for cyclin-dependent kinase inhibitory drugs to cause apoptosis Mol. Cancer Ther., December 1, 2008; 7(12): 3800 - 3806. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Cervera, N. Apostolova, F. L. Crespo, M. Mata, and K. J. McCreath Cells Silenced for SDHB Expression Display Characteristic Features of the Tumor Phenotype Cancer Res., June 1, 2008; 68(11): 4058 - 4067. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sheng, J. Guo, and B. W. Warner Epidermal growth factor receptor signaling modulates apoptosis via p38{alpha} MAPK-dependent activation of Bax in intestinal epithelial cells Am J Physiol Gastrointest Liver Physiol, September 1, 2007; 293(3): G599 - G606. [Abstract] [Full Text] [PDF] |
||||